NCT03093675

Brief Summary

This is a prospective, single-center clinical trial. One hundred and fifty patients affected by adnexal and uterine diseases will be recruited to undergo treatment with robotic assisted laparoscopic procedures using the innovative TELELAP ALF-X Endoscopic Robotic Surgical System with the primary objective of assessing the feasibility, efficacy and safety of this approach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2013

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2014

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

March 16, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 28, 2017

Completed
Last Updated

March 28, 2017

Status Verified

March 1, 2017

Enrollment Period

1.1 years

First QC Date

March 16, 2017

Last Update Submit

March 27, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility and complications of robotic assisted surgery in the treatment of gynecological diseases

    The rate of complications and conversions to laparoscopic/laparotomic surgery will be collected and calculated. As this is a pilot study, no pre-determined success criteria has been set. The number of complications observed during robotic assisted surgery in the treatment of gynecological diseases will be registered.

    Pre-operative to 30 days follow-up

Secondary Outcomes (4)

  • Robotic assisted surgery learning curve assessed through the reduction of procedure times

    Through study completion, on average 1 year

  • Procedure times

    Day of surgical intervention

  • Intra- and post-operative complications

    Day of surgical intervention, 24h post-surgery and after 30-day follow-up

  • Post-operative pain

    End of surgery to 24 hours post-op

Study Arms (1)

TELELAP ALF-X Robotic Surgical System

EXPERIMENTAL

The patients will undergo surgical procedures using the innovative TELELAP ALF-X robotic system.

Device: TELELAP ALF-X Robotic Surgical System

Interventions

The surgical procedures will be performed using the innovative TELELAP ALF-X robotic system, equipped with multiple independent arms. Initial entry will be through a classic open in which the arm with the video camera will be inserted. The device has four independent arms (one for the video camera and three for surgical instruments). Patients will be in the lithotomy position, supported by Allen stirrups and under general anesthesia. The uterus will be manipulated with a multi-use uterine manipulator. After having induced a pneumoperitoneum, high-definition 3D-technology optics will be inserted. Three laparoscopic instruments will be used to complete the procedure. Standard techniques will be used.

TELELAP ALF-X Robotic Surgical System

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe study concerns female-only diseases, adnexal and uterine diseases
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years old
  • Sign the informed consent form
  • BMI ≤ 40
  • A.S.A. Class \< III or IV
  • Ovarian cyst (enucleation/oophorectomy)
  • Prophylactic bilateral oophorectomy
  • Ectopic pregnancy (salpingotomy/salpingectomy)
  • Tubal inflammatory disease (salpingotomy/salpingectomy)
  • Infertility and sterility (treatment of endometriosis, chromo-salpingography, etc.)
  • Benign uterine disease (Fibromatosis, Adenomyosis)
  • Endometrial hyperplasia
  • Stage Ia G1-2 Endometrial tumors
  • Precancerous lesions of the uterine cervix
  • Stage Ia uterine cervical tumors
  • Pelvic endometriosis

You may not qualify if:

  • Pregnancy
  • Liver disease
  • Coagulation disorders
  • Patient internal or anatomical criteria that preclude a laparoscopic approach

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department for the Protection of Health of Women, Newborns, Children and Adolescents A. Gemelli University Polyclinic Catholic University of the Sacred Heart

Rome, 00168, Italy

Location

Related Publications (12)

  • Schreuder HW, Verheijen RH. Robotic surgery. BJOG. 2009 Jan;116(2):198-213. doi: 10.1111/j.1471-0528.2008.02038.x.

    PMID: 19076952BACKGROUND
  • Murphy DG, Hall R, Tong R, Goel R, Costello AJ. Robotic technology in surgery: current status in 2008. ANZ J Surg. 2008 Dec;78(12):1076-81. doi: 10.1111/j.1445-2197.2008.04754.x.

    PMID: 19087046BACKGROUND
  • Heemskerk J, van Gemert WG, de Vries J, Greve J, Bouvy ND. Learning curves of robot-assisted laparoscopic surgery compared with conventional laparoscopic surgery: an experimental study evaluating skill acquisition of robot-assisted laparoscopic tasks compared with conventional laparoscopic tasks in inexperienced users. Surg Laparosc Endosc Percutan Tech. 2007 Jun;17(3):171-4. doi: 10.1097/SLE.0b013e31805b8346.

    PMID: 17581459BACKGROUND
  • Nezhat C, Saberi NS, Shahmohamady B, Nezhat F. Robotic-assisted laparoscopy in gynecological surgery. JSLS. 2006 Jul-Sep;10(3):317-20.

    PMID: 17212887BACKGROUND
  • Advincula AP, Song A. The role of robotic surgery in gynecology. Curr Opin Obstet Gynecol. 2007 Aug;19(4):331-6. doi: 10.1097/GCO.0b013e328216f90b.

    PMID: 17625414BACKGROUND
  • Marchal F, Rauch P, Verhaeghe JL, Guillemin F. [Laparoscopic surgery and robot]. Bull Cancer. 2007 Dec;94(12):1075-80. doi: 10.1684/bdc.2007.0524. French.

    PMID: 18156116BACKGROUND
  • De Ugarte DA, Etzioni DA, Gracia C, Atkinson JB. Robotic surgery and resident training. Surg Endosc. 2003 Jun;17(6):960-3. doi: 10.1007/s00464-002-8745-6. Epub 2003 Mar 28.

    PMID: 12658424BACKGROUND
  • Weinberg L, Rao S, Escobar PF. Robotic surgery in gynecology: an updated systematic review. Obstet Gynecol Int. 2011;2011:852061. doi: 10.1155/2011/852061. Epub 2011 Nov 28.

    PMID: 22190948BACKGROUND
  • Ercoli A, D'asta M, Fagotti A, Fanfani F, Romano F, Baldazzi G, Salerno MG, Scambia G. Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results. Hum Reprod. 2012 Mar;27(3):722-6. doi: 10.1093/humrep/der444. Epub 2012 Jan 11.

    PMID: 22238113BACKGROUND
  • Carvalho L, Abrao MS, Deshpande A, Falcone T. Robotics as a new surgical minimally invasive approach to treatment of endometriosis: a systematic review. Int J Med Robot. 2012 Jun;8(2):160-5. doi: 10.1002/rcs.451. Epub 2011 Dec 9.

    PMID: 22162096BACKGROUND
  • Yim GW, Kim YT. Robotic surgery in gynecologic cancer. Curr Opin Obstet Gynecol. 2012 Feb;24(1):14-23. doi: 10.1097/GCO.0b013e32834daebc.

    PMID: 22123220BACKGROUND
  • Fagotti A, Gagliardi ML, Fanfani F, Salerno MG, Ercoli A, D'Asta M, Tortorella L, Turco LC, Escobar P, Scambia G. Perioperative outcomes of total laparoendoscopic single-site hysterectomy versus total robotic hysterectomy in endometrial cancer patients: a multicentre study. Gynecol Oncol. 2012 Jun;125(3):552-5. doi: 10.1016/j.ygyno.2012.02.035. Epub 2012 Mar 3.

    PMID: 22391483BACKGROUND

MeSH Terms

Conditions

Adnexal DiseasesUterine Diseases

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Giovanni Scambia, Professor

    Department for the Protection of Health of Women, Newborns, Children and Adolescents A. Gemelli University Polyclinic Catholic University of the Sacred Heart

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2017

First Posted

March 28, 2017

Study Start

October 23, 2013

Primary Completion

December 9, 2014

Study Completion

December 9, 2014

Last Updated

March 28, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

Locations